CTOs on the Move

Accent On Health At Latham Inc

www.abcsportsandfitness.com

 
Accent On Health At Latham Inc is a Latham, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 5K-10K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Catholic Health Services

Catholic Health Services is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lasik Vision Institute

Lasik Vision Institute is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Palm Springs, FL. To find more information about Lasik Vision Institute, please visit www.lasikvisioninstitute.com

New Mexico Psychological Association

New Mexico Psychological Association is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rural Wisconsin Health Cooperative

Rural Wisconsin Health Cooperative is a Sauk City, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.